TABLE 1:

Demographic and descriptive statistics for patients imaged at each time categorized by therapeutic risk arm

	Low Risk (n)	Standard/High Risk (n)
Post 1 IV-MTX	21	23
Post 4 IV-MTX	20	21
Post 7 IV-MTX	21	21
End of therapy	20	17
Gender
Male	10	11
Female	12	12
Age at diagnosis (y, ±SD)	5.0 ± 2.7	9.2 ± 4.8

Note.—IV-MTX indicates intravenous methotrexate.